CCL13 Antikörper (Middle Region)
Kurzübersicht für CCL13 Antikörper (Middle Region) (ABIN926919)
Target
Alle CCL13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Purified
-
Immunogen
- CCL13 antibody was raised in rabbit using the middle region of CCL13 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CCL13 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CCL13 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CCL13 (Chemokine (C-C Motif) Ligand 13 (CCL13))
-
Andere Bezeichnung
- CCL13
-
Hintergrund
- Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. CCL13 displays chemotactic activity for monocytes, lymphocytes, basophils and eosinophils, but not neutrophils. This chemokine plays a role in accumulation of leukocytes during inflammation. It may also be involved in the recruitment of monocytes into the arterial wall during artherosclerosis. Synonyms: Polyclonal CCL13 antibody, Anti-CCL13 antibody, chemokine, C-C motif ligand 13 antibody, CKb10 antibody, MCP-4 antibody, MGC17134 antibody, NCC-1 antibody, NCC1 antibody, SCYA13 antibody, SCYL1 antibody.
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-